RBV
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for RBV, covering 2017-10-02 to 2021-02-04. Get the full timeline:
Most recent: Clinical Trial Update: A Phase III Study to Evaluate Efficacy and Safety of TG-2349 in Combination With DAG181 and RBV for HCV Type I Patients [Phase 3]